Obesity and hepatocellular carcinoma

Gastroenterology

Volumn 127, Issue 5 SUPPL., 2004, Pages

  Caldwell, Stephen H ^a,c   Crespo, Deborah M ^b   Kang, Hyon Scott ^a   Al Osaimi, Abdullah M S ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Belem Para   (Brazil)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE HEPATITIS; BILIARY CIRRHOSIS; BODY MASS; CANCER EPIDEMIOLOGY; CANCER RISK; CONFERENCE PAPER; DIABETES MELLITUS; GENE MUTATION; HEPATITIS B; HEPATITIS C; HUMAN; INCIDENCE; LIPID PEROXIDATION; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PREVALENCE; PRIORITY JOURNAL; SENESCENCE; STEATOSIS;

EID: 7044235603     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.09.021     Document Type: Conference Paper

References (46)

1. H.B. El-Serag, H.C. Mason Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 19 1999 221 229
2. H.B. El-Serag, J.A. Davila, N.J. Peteren, K.A. McGlynn The continuing increase in the incidence of hepatocellular carcinoma in the United States an update Ann Intern Med 139 2003 817 823
3. B.A. Neuschwander-Tetri, S.H. Caldwell Nonalcoholic steatohepatitis summary of an AASLD Single Topic Conference Hepatology 37 2003 1202 1219
4. M. Soga, Y. Kishimoto, Y. Kawamura, S. Inagaki, S. Makin, T. Saibara Spontaneous development of hepatocellular carcinomas in the FLS mice with hereditary fatty liver Cancer Lett 196 2003 43 48
5. E.A. Lew, L. Garfinkle Variation in mortality by weight among 750,000 men and women J Chronic Dis 32 1979 563 576
6. A. Wolk, G. Gridley, M. Svensson, O. Nyren, J.K. McLaughlin, J.F. Fraumeni, H.O. Adam A prospective study of obesity and cancer risk (Sweden) Cancer Causes Control 12 2001 13 21
7. H. Moller, A. Mellemgaard, K. Lindvig, J. Olsen Obesity and cancer risk a Danish record-linkage study Eur J Cancer 30A 1994 344 350
8. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, M.J. Thun Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults N Engl J Med 348 2003 1625 1638
9. S. Nair, A. Mason, J. Eason, G. Loss, R.P. Perrillo Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 36 2002 150 155
10. H.O. Adami, W.H. Chow, O. Nyren, C. Berne, M.S. Linet, A. Ekbom, A. Wolk, J.K. McLaughlin, J.F. Fraumeni Jr Excess risk of primary liver cancer in patients with diabetes mellitus J Natl Cancer Inst 89 1996 317 318
11. L. Wideroff, G. Gridley, L. Mellemkjaer, W.H. Chow, M. Linet, S. Keehn, K. Borch-Johnsen, J.H. Olsen Cancer incidence in a population based cohort of patients hospitalized with diabetes mellitus in Denmark J Natl Cancer Inst 89 1997 1360 1365
12. P. Lagiou, H. Kuper, S.O. Stuver, A. Tzonou, D. Trichopoulos, H.-O. Adami Role of diabetes mellitus in the etiology of hepatocellular carcinoma J Natl Cancer Inst 92 2000 1096 1099
13. H.B. El-Serag, P.A. Richardson, J.E. Everhart The role of diabetes in hepatocellular carcinoma a case-control study among United States veterans Am J Gastroenterol 96 2001 2462 2467
14. H.B. El-Serag, T. Tran, J.E. Everhart Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma Gastroenterology 126 2004 460 468
15. E.E. Powell, W.G. Cooksley, R. Hanson, J. Searll, J.W. Halliday, L.W. Powell The natural history of nonalcoholic steatohepatitis a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74 80
16. H.P. Cotrim, R. Parana, E. Braga, L. Lyra Nonalcoholic steatohepatitis and hepatocellular cancer natural history? Am J Gastroenterol 95 2000 3018 3019
17. Y. Zen, K. Katayanagi, K. Tsuneyama, K. Harada, I. Araki, Y. Nakanuma Hepatocellular carcinoma arising in non-alcoholic steatohepatitis Pathol Int 51 2001 127 131
18. M. Shimada, E. Hashimoto, M. Taniai, K. Hasegawa, H. Okuda, N. Hayashi, K. Takasaki, J. Ludwig Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis J Hepatol 37 2002 154 160
19. S.H. Caldwell, D.M. Harris, J. Patrie, E.E. Hespenheide Is NASH underdiagnosed among African Americans? Am J Gastroenterol 97 2002 1496 1500
20. J.D. Browning, K.S. Kumar, M.H. Saboorian, D.L. Thiele Ethnic differences in the prevalence of cryptogenic cirrhosis Am J Gastroenterol 99 2004 292 298
21. J.A. Yanovski, S.Z. Yanovski, K.M. Filmer, V.S. Hubbard, N. Avila, B. Lewis, J.C. Reynolds, M. Flood Differences in body composition of black and white girls Am J Clin Nutr 64 1996 833 839
22. A.C. Perry, E.B. Applegate, M.L. Jackson, S. Deprima, R.B. Goldberg, R. Ross, L. Kempner, B.B.L. Feldman Racial differences in visceral adipose tissue but not in anthropometric markers of health-related variables J Appl Physiol 89 2000 636 643
23. S.H. Caldwell, D.H. Oelsner, J.C. Iezzoni, E.E. Hespenheide, E.H. Battle, C.J. Driscoll Cryptogenic cirrhosis clinical characterization and risk factors for underlying disease Hepatology 29 1999 664 669
24. A. Poonawala, S.P. Nair, P.J. Thuluvath Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis a case-control study Hepatology 32 2000 689 692
25. M.J. Contos, W. Cales, R.K. Sterling, V.A. Lukeric, M.L. Shiffman, A.S. Mills, R.A. Fisher, J. Ham, A.J. Sanyal Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis Liver Transpl 7 2001 363 373
26. G. Ayata, F.D. Gordon, W.D. Lewis, E. Pomfret, J.J. Pomposelli, R.L. Jenkins, U. Khettry Cryptogenic cirrhosis clinicopathologic findings at and after liver transplantation Hum Pathol 33 2002 1098 1104
27. J.A. Marrero, R.J. Fontana, G.L. Su, H.S. Conjeevaram, D.M. Emick, A.S. Lok NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States Hepatology 36 2002 1349 1354
28. E. Bugianesi, N. Leone, E. Vanni, G. Marchesini, F. Brunello, P. Carucci, A. Musso, P. De Paolis, L. Cappussotti, M. Salizzoni, M. Rizzetto Expanding the natural history of nonalcoholic steatohepatitis from cryptogenic cirrhosis to hepatocellular cancer Gastroenterology 123 2002 134 140
29. J.P. Ong, Z.M. Younossi Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis? Gastroenterology 123 2002 375 378
30. V. Ratziu, L. Bonyhay, V. Di Martino, F. Charlotte, L. Cavallaro, M.-H. Sayegh-Tainturier, P. Giral, A. Grimaldi, P. Opolon, T. Poynard Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis Hepatology 35 2002 1485 1493
31. H.C. Pitot Pathways of progression in hepatocarcinogenesis Lancet 358 2001 859 860
32. A.Q. Yang, H.Z. Lin, J. Hwang, V.P. Chacko, A.M. Diehl Hepatic hyperplasia in noncirrhotic fatty liver is obesity-related hepatic steatosis a premalignant condition? Cancer Res 61 2001 5016 5023
33. T. Roskams, S.Q. Yang, A. Koteish, A. Durnez, R. DeVos, X. Huang, R. Achten, C. Verslype, M. Diehl Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease Am J Pathol 163 2003 1301 1311
34. H. Kim, C. Park, K.-H. Han, J. Choi, Y.B. Kim, J.K. Kim, Y.N. Park Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype J Hepatol 40 2004 298 304
35. S. Yang, A. Koteish, H. Lin, J. Huang, T. Roskams, V. Dawson, A.M. Diehl Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease Hepatology 39 2004 403 411
36. H. Dominguez-Malagon, S. Gaytan-Graham Hepatocellular carcinoma an update Ultrastruct Pathol 25 2001 497 516
37. W. Hu, Z. Feng, J. Eveleigh, G. Iyer, J. Pan, S. Amin, F.L. Chung, M.S. Tang The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma Carcinogenesis 23 2002 1781 1789
38. J.C. Hsu, J.Y. Peng, P.L. Lai, J.C. Sheu, D.S. Chen, L.I. Lin, B.L. Slagle, J.S. Butel Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinoma Cancer 73 1994 42 47
39. A.E. Feldstein, A. Canbay, P. Angulo, M. Taniai, L.J. Burgart, K.D. Lindor, G.J. Gores Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis Gastroenterology 125 2003 437 443
40. A. Rashid, T.C. Wu, C.C. Huang, C.H. Chen, H.Z. Lin, S.Q. Yang, F.Y. Lee, A.M. Diehl Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver Hepatology 29 1999 1131 1138
41. W. Rossmanith, R. Schulte-Hermann Biology of transforming growth factor beta in hepatocarcinogenesis Microsc Res Tech 52 2001 430 436
42. A. Sanchez, V.M. Factor, I.S. Schroeder, P. Nagy, S.S. Thorgeirsson Activation of NF-κB and STAT3 in rat oval cells during 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration Hepatology 39 2004 376 385
43. S. Yu, S. Rao, J.K. Reddy Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis Curr Mol Med 3 2003 561 572
44. J. Leng, C. Han, A.J. Demetris, G.K. Michalopoulos, T. Wu Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through AKT activation evidence for AKT inhibition in celecoxib-induced apoptosis Hepatology 38 2003 756 768
45. W.D. DuBois Cyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switch Proc Natl Acad Sci U S A 101 2004 591 596
46. W.-N.P. Lee, S. Lim, S. Bassilian, E.A. Bergner, J. Edmond Fatty acid cycling in human hepatoma cells and the effects of troglitazone J Biol Chem 273 1998 20929 20934